在患有外围神经病变,肝毒性和反复跌倒的老年患者中,素诱导的毒性
Nicholas Joseph Waters1, Nadia Mouchaileh2, Tessa Low2
1Austin Health, Heidelberg, Victoria, Australia nick.waters@austin.org.au.
BMJ case reports
|January 19, 2025
概括
这份案例报告强调了家庭西林在老年患者中的毒性,导致严重的移动性问题和肝损伤. 治疗药物监测对于安全使用埃菲克西林至关重要,特别是在老年人中.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
背景情况:
- 珀赫西林是耐火性疾病的有效抗风脉剂.
- 它的使用受到神经毒性和肝毒性风险的限制,通常是由于代谢受损.
- 高血度与药物不良反应有关.
研究的目的:
- 报告一个老年男性的家庭西林诱导的毒性病例.
- 强调对家庭西林治疗药物监测的重要性.
- 强调需要对老年患者药物不良反应保持警.
主要方法:
- 一个70多岁的男性患者的病例报告.
- 临床评估,包括移动性和肝功能的评估.
- 实验室检测,包括血清家庭克西林水平.
- 排除患者症状的其他病因.
主要成果:
- 患者经过6个月的fermexiline治疗后出现了肝毒性,下肢虚弱和运动能力下降.
- 在住院期间,高血清 perhexiline 水平证实了毒性.
- 停止服用perekxiline导致肝功能和运动能力显著改善.
结论:
- 珀赫西林毒性可以表现为严重的神经和肝脏并发症.
- 治疗药物监测对于管理fermexiline治疗至关重要.
- 易受伤害的老年患者需要仔细考虑药物不良反应.
相关概念视频
Parkinson's Disease: Treatment
202
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
202
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
78
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
78
Anticholinesterase Agents: Poisoning and Treatment
780
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
780
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
613
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
613


